Literature DB >> 8738076

Conception rates and assisted reproduction in subfertility due to unilateral cryptorchidism.

A M Mahmoud1, F H Comhaire, D E Abdel-Rahim, K M Abdel-Hafez.   

Abstract

During 774 spontaneous cycles and 87 cycles of assisted reproduction, the conception rates were evaluated in 48 infertile couples in whom unilateral cryptorchidism was the causal factor. In spite of adjuvant therapy of the male partner, the spontaneous conception rate was very low (1% per cycle). Intra-uterine insemination (IUI) and conventional in vitro fertilization (IVF) resulted in similar success rates of 6.1 and 8.7% per cycle/attempt respectively. After intra-cyto-plasmic sperm injection (ICSI), 46.7% pregnancies were obtained per attempt, and sperm requirements for the latter treatment to be successful were lower than for IUI. It is concluded that subfertility in men with unilateral cryptorchidism is severe, conventional IVF has little advantage, but ICSI is highly successful.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738076     DOI: 10.1111/j.1439-0272.1996.tb02772.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  4 in total

Review 1.  The biology of infertility: research advances and clinical challenges.

Authors:  Martin M Matzuk; Dolores J Lamb
Journal:  Nat Med       Date:  2008-11-06       Impact factor: 53.440

Review 2.  Update on cryptorchidism: endocrine, environmental and therapeutic aspects.

Authors:  F Brucker-Davis; G Pointis; D Chevallier; P Fenichel
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

Review 3.  Orchidopexy and its impact on fertility.

Authors:  Feilim Murphy; Thambipillai Sri Paran; Prem Puri
Journal:  Pediatr Surg Int       Date:  2007-03-13       Impact factor: 2.003

Review 4.  Fertility of Cryptorchid Testis-An Unsolved Mistery.

Authors:  Carmen Iulia Ciongradi; Ioan Sârbu; Codruța Olimpiada Iliescu Halițchi; Diana Benchia; Klara Sârbu
Journal:  Genes (Basel)       Date:  2021-11-26       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.